摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-amino-6-methoxy-quinoline hydrobromide | 106492-78-8

中文名称
——
中文别名
——
英文名称
8-amino-6-methoxy-quinoline hydrobromide
英文别名
8-Amino-6-methoxyquinoline hydrobromide;6-methoxyquinolin-8-amine;hydrobromide
8-amino-6-methoxy-quinoline hydrobromide化学式
CAS
106492-78-8
化学式
BrH*C10H10N2O
mdl
——
分子量
255.114
InChiKey
WGYQQCWLZRGIKB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    48.1
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    8-amino-6-methoxy-quinoline hydrobromide 在 palladium on activated charcoal 吡啶 、 sodium azide 、 氢气 作用下, 以 甲醇二氯甲烷N,N-二甲基甲酰胺丙酮 为溶剂, 反应 2.33h, 生成 4-aminomethyl-N-(6-methoxy-quinolin-8-yl)-benzenesulfonamide
    参考文献:
    名称:
    用于Zn(II)荧光传感的二氧化硅纳米粒子:探索共价策略。
    摘要:
    制备并研究了二氧化硅纳米颗粒(直径约15 nm),该纳米颗粒包含与二氧化硅网络共价连接的6-甲氧基-8-(对甲苯磺酰胺基)-喹啉(TSQ)作为Zn(II)荧光探针。 Zn(II)荧光化学传感器。该系统以亚微摩尔灵敏度选择性地检测富水溶液中的Zn(II)离子:在Cu(II)和Cd(II)离子的唯一干扰下,可以测量0.13 microM浓度的Zn(II)。与游离TSQ相比,基于纳米粒子的系统具有可以在水溶液中使用而不会发生聚集问题的优势,同时,它们还具有相似的Zn(II)亲和力和感测能力。向颗粒中添加第二种对底物不敏感的荧光团可实现比例传感器。
    DOI:
    10.1002/chem.200600624
点击查看最新优质反应信息

文献信息

  • Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof
    申请人:Cazelles Jerome
    公开号:US20070021423A1
    公开(公告)日:2007-01-25
    The invention relates to dual molecule compounds containing a peroxide derivative, to processes for the synthesis of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment and prevention of malaria comprising administering such compounds and such pharmaceutical compositions.
    这项发明涉及含有过氧化物衍生物的双分子化合物,涉及合成这种化合物的方法,涉及包括这种化合物的药物组合物,以及涉及通过给予这种化合物和这种药物组合物来治疗和预防疟疾的方法。
  • Linked dihydrazone-based charge transport compounds
    申请人:Tokarski Zbigniew
    公开号:US20050058916A1
    公开(公告)日:2005-03-17
    Improved organophotoreceptors comprise: (a) a charge transport compound having the formula where n is an integer from 0 to 1; X is an (N,N-disubstituted)arylamine group; Ar is an aryl group or a heterocyclic group; A is a first linking group with the formula —(CH 2 ) p — which can be branched or linear, where p is an integer from 3 to 20 inclusive and where one or more methylene groups can be optionally replaced by O, S, a carbonyl group, urethane, urea, an ester group, a —NR 16 group, a CHR 17 group, or a CR 18 R 19 group where R 16 , R 17 , R 18 and R 19 are, independently, H, hydroxyl, thiol, an amine group, an alkyl group, an alkaryl group, an aryl group, or part of a ring; and B is a second linking group having the formula -Q-Z-Q′-, where Q and Q′ are, independently, O, S, or NR 1 , where R 1 is an H, an alkyl group, an alkaryl group or an aryl group, and Z comprises a heterocyclic group; (b) a charge generating compound; and (c) an electrically conductive substrate over which said charge transport compound and said charge generating compound are located.
    改进的有机光电受体包括:(a)具有以下式子的电荷传输化合物,其中n是从0到1的整数;X是(N,N-二取代)芳胺基团;Ar是芳基团或杂环基团;A是第一连接基团,具有以下式子—(CH2)p—,可以是支链或直链,其中p是从3到20的整数,其中一个或多个亚甲基可以选择性地被O,S,羰基,脲,尿素,酯基,—NR16基团,CHR17基团或CR18R19基团替换,其中R16,R17,R18和R19分别是H,羟基,硫醇,胺基,烷基,烷基芳基基团,芳基基团或环的一部分;B是第二连接基团,具有以下式子-Q-Z-Q',其中Q和Q'是独立的O,S或NR1,其中R1是H,烷基,烷基芳基基团或芳基基团,Z包括一个杂环基团;(b)电荷生成化合物;和(c)电导基板,在该电导基板上,所述电荷传输化合物和所述电荷生成化合物被定位。
  • METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT
    申请人:Jacobson Alan
    公开号:US20110190285A1
    公开(公告)日:2011-08-04
    The present invention provides methods of treating a botulinum toxin related condition in a subject. In certain embodiments, the methods involve administering a compound of the following formulas: (I), (II), (III), (IV), (V).
    本发明提供了治疗受体肉毒毒素相关疾病的方法。在某些实施例中,该方法涉及到给受体注射以下化合物:(I)、(II)、(III)、(IV)、(V)。
  • COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES
    申请人:Jacobson Alan
    公开号:US20110034521A1
    公开(公告)日:2011-02-10
    The present invention provides compounds and methods for treating zinc matrix metalloprotease dependent diseases. In certain embodiments, the compounds of the present invention have the following formulas:
    本发明提供了化合物和治疗锌基金属蛋白酶依赖性疾病的方法。在某些实施例中,本发明的化合物具有以下结构式:
  • Zn2+ dependent DNA binders based on terminally modified peptide nucleic acids
    作者:Iris Boll、Larisa Kovbasyuk、Roland Krämer、Thomas Oeser、Andriy Mokhir
    DOI:10.1016/j.bmcl.2006.02.002
    日期:2006.5
    Two ligand-intercalator-peptide nucleic acid conjugates (L-NADI-PNAs) have been synthesized. Affinity of these conjugates to their complementary DNAs was found to be affected by Zn2+. The magnitude of this effect Could be controlled by a variation of the ligand. Upon binding Zn2+ the L-NADI-PNAs form positively charged ZnL complexes, which interact 2 with the negatively charged DNA backbone. This electrostatic interaction stabilizes PNA/DNA duplexes. It has been found that Zn2+ dependent stabilization takes place only if the ZnL complex has a higher total positive charge than the ligand. Linear correlation has been observed between Zn2+ induced stabilization of PNA/DNA duplexes and difference of charges of the ZnL complex and the ligand. (C) 2006 Elsevier Ltd. All rights reserved.
查看更多